VRTX
Vertex PharmaceuticalsABOUT VRTX
Vertex Pharmaceuticals dominates the cystic fibrosis (CF) treatment market with its Trikafta franchise, which treats approximately 90% of CF patients. The company is expanding into pain (suzetrigine, a non-opioid pain drug), kidney disease, sickle cell disease, and gene editing through its partnership with CRISPR Therapeutics on Casgevy.
WHY TRACK VRTX ON SQUAWKFLOW
VRTX options flow is critical around CF franchise updates and pipeline diversification catalysts. Large call spreads often appear before pain program clinical readouts, signaling institutional conviction on the non-opioid opportunity.
VRTX DATA ON SQUAWKFLOW
Options Flow
Real-time VRTX sweeps, blocks, and unusual options activity
Dark Pool Prints
Institutional VRTX dark pool trades with size and sentiment
GEX Dashboard
VRTX gamma exposure levels, call/put walls, and GEX flip
AI Narration
AI-powered analysis of VRTX market microstructure in real time
News Sentiment
VRTX news with AI sentiment scoring and impact analysis
Sector Context
Healthcare sector rotation and relative strength vs peers
Track VRTX Live
Real-time options flow, GEX dashboard, dark pool alerts, and AI narration — free.
Open Terminal →LEARN MORE
A thorough explanation of implied volatility, how it is calculated, what it means, and how to use it in trading.
Max Pain Theory in Options: How It Works and Whether to Trust ItUnderstanding the max pain theory, how to calculate it, its track record, and practical ways to use it in your trading.